Found 3 articles for: "Acanthosis Nigricans"
Evaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans
July 2026 | Volume 25 | Issue 7 | Original Article | 615 | Copyright © July 2026
Background: There are currently no FDA-approved pharmacologic treatments for acanthosis nigricans (AN), a common dermatologic condition characterized by hyperpigmented, velvety p...
Read MoreVisual Assessment Tools and Therapeutic Implications for Acanthosis Nigricans
February 2025 | Volume 24 | Issue 2 | Original Article | 156 | Copyright © February 2025
Acanthosis nigricans significantly impacts individuals with skin of color. No United States Food and Drug Administration (FDA)-approved therapy exists for acanthosis nigricans. This review evalua...
Read MoreThe Obesity Epidemic and the Rise of Acanthosis Nigricans – A Case for Lifestyle Medicine
July 2020 | Volume 19 | Issue 7 | Features | 774 | Copyright © July 2020
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.